For the third time in three years, FDA has added new warnings to labeling of testosterone products. This time the warning is about the risks associated with the abuse and dependence of testosterone and other anabolic androgenic steroids.
Another Testosterone Warning – This Time For Abuse
Action follows agency review of 81 adverse events reported with testosterone/anabolic androgenic steroid misuse, abuse, or dependence over 45 years; discussions continue on cardiovascular study.
